Finance ForgeBETA
Crear cuenta gratis
1)Empresas2)Rankings3)Iniciar sesión
Finance Forge Terminal v1.49.5
PrivacidadTérminosCookiesAviso Legal
● Connected
GEHC US Equity
GE HealthCare Technologies Inc.
64.22USD
Healthcare
Medical Devices
96)Comparar97)Tesis →
Market Cap
$29.0B
Shares Outstanding
452M
EV/EBITDA
11.3×
— Annual —FY2025
Revenue
$20.6B
Gross Margin
40.0%
Operating Margin
13.4%
Net Margin
10.1%
FCF Margin
7.3%
ROE
20.1%
ROCE
9.9%
Net Debt/EBITDA
1.8×
Current Ratio
1.37
D/E Ratio
0.96
Dividend Yield
0.2%
FCF / Share
3.33
Book Value / Share
22.98
GEHC US Equity
64.22USD
Tesis →

GE HealthCare Technologies Inc. (GEHC): análisis fundamental y valoración

GE HealthCare Technologies Inc. cotiza a 64.22 USD y tiene una capitalización bursátil de $29.0B. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud

Price History
Loading...
Perfil
BolsaNasdaqPaísUnited StatesEmpleados54,000Beta0.82Web↗ www.gehealthcare.com

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced …

Múltiplos de Valoración
P/E (Annual)
13.9×
P/E (TTM)
—
P/FCF (Annual)
19.3×
P/FCF (TTM)
—
EV/EBITDA
11.3×
EV/Revenue
1.7×
P/Sales
1.4×
P/Book
2.8×
Rentabilidad (Último Anual)
Gross Margin
40.0%
Operating Margin
13.4%
Net Margin
10.1%
FCF Margin
7.3%
ROE
20.1%
ROCE
9.9%
ROA
5.7%
Effective Tax Rate
24.7%
Métricas TTM
Revenue TTM
—
Gross Profit TTM
—
Operating Income TTM
—
Net Income TTM
—
FCF TTM
—
EPS TTM
—
Quarters Used
—
TTM Period
—
Solidez del Balance
Net Debt
$5.5B
Net Debt / EBITDA
1.8×
Debt / Equity
0.96
Current Ratio
1.37
Interest Coverage
6.3×
Working Capital
$3.4B
Book Value / Share
22.98
Net Debt / Share
12.2
Crecimiento (YoY)
Revenue YoY
+4.8%
Net Income YoY
+4.6%
FCF YoY
-3.1%
EPS Diluted YoY
+4.8%
Retorno al Accionista
Dividend Yield
0.2%
Payout Ratio
3.1%
FCF / Share
3.33
CapEx % Revenue
2.3%
Rev / Employee
381,944
Próximos Eventos
Ex-Dividendo
2026-10-23
Pago Dividendo
2026-11-13
Historial EPS
Periodo2026-102026-072026-042026-02
Real—$1.13$0.99$1.44
Estimado$1.21$1.04$1.05$1.40
Sorpresa—+8.7%-5.7%+2.9%
Empresas similares
Smart Money
vs Sector: Healthcare (1130 empresas)
MétricaGEHCMediana SectorΔ
Gross Margin40.0%57.0%-17.0%
Operating Margin13.4%-38.6%+52.0%
Net Margin10.1%-33.6%+43.7%
FCF Margin7.3%-13.9%+21.2%
ROE20.1%-40.4%+60.5%
ROA5.7%-32.0%+37.7%
Current Ratio1.372.84-1.47
Debt / Equity0.960.28+0.68
Scoring Fundamental
Piotroski F-Score
4/ 9Débil
✓F1ROA positivo (rentabilidad activos)
✓F2Flujo caja operativo positivo
✗F3ROA mejora vs año anterior
✗F4Calidad de beneficios (OCF > ROA)
✗F5Apalancamiento baja
✓F6Liquidez mejora (current ratio)
✓F7Sin dilución accionarial
✗F8Margen bruto mejora
✗F9Rotación activos mejora
Altman Z-ScoreZona de Riesgo
1.77
x1_working_capital0.092
x2_retained_earnings0.143
x3_ebit0.075
x4_market_equity1.095
x5_sales0.559
>2.99 segura · 1.81–2.99 gris · <1.81 riesgo
Capital Allocation
5/ 8Moderada
✓FCF+Free cash flow positivo
✗FCFmMargen FCF > 10%
✓DilucSin dilución significativa (< 2%/año en 3 años)
✗Rev↑Revenue CAGR 3 años > 5%
✗ROCERetorno sobre capital empleado > 10%
✓DeudaDeuda neta/EBITDA < 3× (o posición de caja neta)
✓Mg↑Margen operativo ≥ hace 2-3 años (tolerancia -2pp)
✓Inv.R&D + Capex > 3% de revenue (reinversión en el negocio)
Histórico Piotroski F-Score
Histórico de Múltiplos